575 related articles for article (PubMed ID: 8012987)
1. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
Lindström P; Bergh A; Holm I; Damber JE
Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
[TBL] [Abstract][Full Text] [Related]
3. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
4. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.
Miyake H; Nelson C; Rennie PS; Gleave ME
Cancer Res; 2000 Jan; 60(1):170-6. PubMed ID: 10646870
[TBL] [Abstract][Full Text] [Related]
5. Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate.
Landström M; Damber JE; Bergh A
Cancer Res; 1994 Aug; 54(16):4281-4. PubMed ID: 7913874
[TBL] [Abstract][Full Text] [Related]
6. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
7. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
8. Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.
Nickerson T; Miyake H; Gleave ME; Pollak M
Cancer Res; 1999 Jul; 59(14):3392-5. PubMed ID: 10416600
[TBL] [Abstract][Full Text] [Related]
9. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
Miyake H; Nelson C; Rennie PS; Gleave ME
Cancer Res; 2000 May; 60(9):2547-54. PubMed ID: 10811138
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis in androgen-independent mouse mammary tumor cells induced by 5-fluorodeoxyuridine but not by androgen withdrawal.
Furuya Y; Shimazaki J
Anticancer Res; 1996; 16(5A):2613-8. PubMed ID: 8917359
[TBL] [Abstract][Full Text] [Related]
12. Subcellular distribution in vivo of testosterone and salt extractability of nuclear androgen complexes in the prostate and prostatic adenocarcinoma: effect of estrogen treatment.
Batra S; Wännman H; Alenfall J; Forsgren B
In Vivo; 1992; 6(6):573-8. PubMed ID: 1296804
[TBL] [Abstract][Full Text] [Related]
13. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal.
Walensky LD; Coffey DS; Chen TH; Wu TC; Pasternack GR
Cancer Res; 1993 Oct; 53(19):4720-6. PubMed ID: 7691403
[TBL] [Abstract][Full Text] [Related]
14. Expression of glutathione-peroxidase (GSH-PO) in the rat ventral prostate--effect of castration and administration of testosterone.
Murakoshi M; Ikeda R; Tagawa M; Suzuki M; Takekoshi S; Watanabe K
Tokai J Exp Clin Med; 1997 Sep; 22(3):111-8. PubMed ID: 9618832
[TBL] [Abstract][Full Text] [Related]
15. Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland.
Shabsigh A; Ghafar MA; de la Taille A; Burchardt M; Kaplan SA; Anastasiadis AG; Buttyan R
J Cell Biochem; 2001; 81(3):437-44. PubMed ID: 11255226
[TBL] [Abstract][Full Text] [Related]
16. Quiescence in R3327-G rat prostate tumors after androgen ablation.
Pollack A; Joon DL; Wu CS; Sikes C; Hasegawa M; Terry NH; White RA; Zagars GK; Meistrich ML
Cancer Res; 1997 Jun; 57(12):2493-500. PubMed ID: 9192831
[TBL] [Abstract][Full Text] [Related]
17. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
18. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
Ip MM; Milholland RJ; Rosen F
Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
Kyprianou N; English HF; Isaacs JT
Cancer Res; 1990 Jun; 50(12):3748-53. PubMed ID: 2340521
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
